Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice

Alberto Malerba; Paul S Sharp; Ian R Graham; Virginia Arechavala-Gomeza; Keith Foster; Francesco Muntoni; Dominic J Wells; George Dickson

doi:10.1038/mt.2010.261

Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice

Alberto Malerba
, Paul S Sharp
, Ian R Graham
, Virginia Arechavala-Gomeza
, Keith Foster
, Francesco Muntoni
, Dominic J Wells
, George Dickson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	345-354
Journal	Molecular Therapy
Volume	19
Issue number	2
Early online date	23 Nov 2010
DOIs	https://doi.org/10.1038/mt.2010.261
Publication status	Published - Feb 2011

Access to Document

10.1038/mt.2010.261

http://www.nature.com/mt/journal/v19/n2/full/mt2010261a.html

Cite this

@article{46e7b3cf519b4620ae6d9921ae620324,

title = "Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice",

author = "Alberto Malerba and Sharp, \{Paul S\} and Graham, \{Ian R\} and Virginia Arechavala-Gomeza and Keith Foster and Francesco Muntoni and Wells, \{Dominic J\} and George Dickson",

year = "2011",

month = feb,

doi = "10.1038/mt.2010.261",

language = "English",

volume = "19",

pages = "345--354",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice

AU - Malerba, Alberto

AU - Sharp, Paul S

AU - Graham, Ian R

AU - Arechavala-Gomeza, Virginia

AU - Foster, Keith

AU - Muntoni, Francesco

AU - Wells, Dominic J

AU - Dickson, George

PY - 2011/2

Y1 - 2011/2

U2 - 10.1038/mt.2010.261

DO - 10.1038/mt.2010.261

M3 - Article

C2 - 21102560

SN - 1525-0016

VL - 19

SP - 345

EP - 354

JO - Molecular Therapy

JF - Molecular Therapy

IS - 2

ER -